These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20166960)

  • 1. Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases.
    Raddatz R; Tao M; Hudkins RL
    Curr Top Med Chem; 2010; 10(2):153-69. PubMed ID: 20166960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H3 antagonists as wake-promoting and pro-cognitive agents.
    Stocking EM; Letavic MA
    Curr Top Med Chem; 2008; 8(11):988-1002. PubMed ID: 18673168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders.
    Esbenshade TA; Browman KE; Bitner RS; Strakhova M; Cowart MD; Brioni JD
    Br J Pharmacol; 2008 Jul; 154(6):1166-81. PubMed ID: 18469850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.
    Witkin JM; Nelson DL
    Pharmacol Ther; 2004 Jul; 103(1):1-20. PubMed ID: 15251226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease.
    Brioni JD; Esbenshade TA; Garrison TR; Bitner SR; Cowart MD
    J Pharmacol Exp Ther; 2011 Jan; 336(1):38-46. PubMed ID: 20864505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine H3-receptor inverse agonists as novel antipsychotics.
    Ito C
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):132-6. PubMed ID: 20021346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H3 receptor antagonists go to clinics.
    Sander K; Kottke T; Stark H
    Biol Pharm Bull; 2008 Dec; 31(12):2163-81. PubMed ID: 19043195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H
    Ghamari N; Zarei O; Arias-Montaño JA; Reiner D; Dastmalchi S; Stark H; Hamzeh-Mivehroud M
    Pharmacol Ther; 2019 Aug; 200():69-84. PubMed ID: 31028835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of histamine H₃ antagonists/inverse agonists.
    Lebois EP; Jones CK; Lindsley CW
    Curr Top Med Chem; 2011; 11(6):648-60. PubMed ID: 21261594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches for the treatment of cognitive deficits in CNS disease.
    Hudkins RL
    Curr Top Med Chem; 2010; 10(2):142-3. PubMed ID: 20374195
    [No Abstract]   [Full Text] [Related]  

  • 11. Histamine H3 receptor function and ligands: recent developments.
    Singh M; Jadhav HR
    Mini Rev Med Chem; 2013 Jan; 13(1):47-57. PubMed ID: 22931528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity.
    de Lera Ruiz M; Zheng J; Berlin MY; McCormick KD; Aslanian RG; West R; Hwa J; Lachowicz J; van Heek M
    Bioorg Med Chem Lett; 2013 Nov; 23(21):6004-9. PubMed ID: 24035485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain.
    Guryn R; Staszewski M; Kopczacki P; Walczyski K
    Med Chem; 2016; 13(1):65-76. PubMed ID: 27220560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Hydroxypiperidines and Their Flexible 3-(Amino)propyloxy Analogues as Non-Imidazole Histamine H₃ Receptor Antagonist: Further Structure⁻Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation.
    Olszewska B; Stasiak A; McNaught Flores D; Fogel WA; Leurs R; Walczyński K
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
    Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
    Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H3 receptor antagonists ameliorate attention deficit/hyperactivity disorder-like behavioral changes caused by neonatal habenula lesion.
    Kim YJ; Goto Y; Lee YA
    Behav Pharmacol; 2018 Feb; 29(1):71-78. PubMed ID: 28863002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments around histamine H(3) receptor antagonists/inverse agonists: a patent review (2010 - present).
    Łażewska D; Kieć-Kononowicz K
    Expert Opin Ther Pat; 2014 Jan; 24(1):89-111. PubMed ID: 24131059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
    Esbenshade TA; Fox GB; Cowart MD
    Mol Interv; 2006 Apr; 6(2):77-88, 59. PubMed ID: 16565470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H
    Riddy DM; Cook AE; Shackleford DM; Pierce TL; Mocaer E; Mannoury la Cour C; Sors A; Charman WN; Summers RJ; Sexton PM; Christopoulos A; Langmead CJ
    Neuropharmacology; 2019 Jan; 144():244-255. PubMed ID: 30359639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of the benzazepine class of histamine H3 receptor antagonists.
    Wilson DM; Apps J; Bailey N; Bamford MJ; Beresford IJ; Briggs MA; Calver AR; Crook B; Davis RP; Davis S; Dean DK; Harris L; Heightman TD; Panchal T; Parr CA; Quashie N; Steadman JG; Schogger J; Sehmi SS; Stean TO; Takle AK; Trail BK; White T; Witherington J; Worby A; Medhurst AD
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6897-901. PubMed ID: 24161834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.